Pfizer India (PFIZER) Q1 25/26 earnings summary

Executive summary

• Unaudited financial results for the quarter ended June 30, 2025, were approved by the Board on August 13, 2025.

• Financials prepared in accordance with Ind AS and reviewed by statutory auditors with no modifications.

Financial highlights

• Revenue from operations for Q1 FY26 was ₹603.05 crore, up from ₹562.86 crore year-over-year.

• Total income for the quarter was ₹670.22 crore, compared to ₹604.70 crore in Q1 FY25.

• Net profit for the quarter stood at ₹191.75 crore, up from ₹150.71 crore year-over-year.

• Earnings per share (EPS) for the quarter was ₹41.91, compared to ₹32.94 in Q1 FY25.

Key financial ratios and metrics

• Gross margin improved as cost of materials consumed increased at a slower rate than revenue.

• Operating expenses, including employee benefits and other expenses, remained stable relative to revenue growth.